Department of Oral Medicine, Cannon Research Center, Carolinas HealthCare System, Charlotte, NC, USA.
Department of Bioinformatics and Genomics, University of North Carolina at Charlotte, Charlotte, NC, USA.
Support Care Cancer. 2018 Aug;26(8):2695-2705. doi: 10.1007/s00520-018-4096-2. Epub 2018 Feb 23.
Oral mucositis (OM) is a major dose-limiting side effect of chemotherapy and radiation used in cancer treatment. Due to the complex nature of OM, currently available drug-based treatments are of limited efficacy.
Our objectives were (i) to determine genes and molecular pathways associated with OM and wound healing using computational tools and publicly available data and (ii) to identify drugs formulated for topical use targeting the relevant OM molecular pathways.
OM and wound healing-associated genes were determined by text mining, and the intersection of the two gene sets was selected for gene ontology analysis using the GeneCodis program. Protein interaction network analysis was performed using STRING-db. Enriched gene sets belonging to the identified pathways were queried against the Drug-Gene Interaction database to find drug candidates for topical use in OM.
Our analysis identified 447 genes common to both the "OM" and "wound healing" text mining concepts. Gene enrichment analysis yielded 20 genes representing six pathways and targetable by a total of 32 drugs which could possibly be formulated for topical application. A manual search on ClinicalTrials.gov confirmed no relevant pathway/drug candidate had been overlooked. Twenty-five of the 32 drugs can directly affect the PTGS2 (COX-2) pathway, the pathway that has been targeted in previous clinical trials with limited success.
Drug discovery using in silico text mining and pathway analysis tools can facilitate the identification of existing drugs that have the potential of topical administration to improve OM treatment.
口腔黏膜炎(OM)是癌症治疗中化疗和放疗的主要剂量限制副作用。由于 OM 的复杂性,目前可用的基于药物的治疗方法疗效有限。
我们的目标是(i)使用计算工具和公开可用的数据确定与 OM 和伤口愈合相关的基因和分子途径,以及(ii)确定针对相关 OM 分子途径的局部使用的药物配方。
通过文本挖掘确定 OM 和伤口愈合相关的基因,并使用 GeneCodis 程序选择两个基因集的交集进行基因本体分析。使用 STRING-db 进行蛋白质相互作用网络分析。查询属于鉴定途径的富集基因集,以找到可用于 OM 局部应用的药物候选物。
我们的分析确定了 447 个共同存在于“OM”和“伤口愈合”文本挖掘概念中的基因。基因富集分析产生了代表六个途径的 20 个基因,共有 32 种药物可以靶向这些途径,这些药物可能被制成局部应用制剂。在 ClinicalTrials.gov 上的手动搜索证实没有遗漏任何相关的途径/药物候选物。这 32 种药物中的 25 种可以直接影响 PTGS2(COX-2)途径,该途径是以前临床试验中靶向的途径,但疗效有限。
使用计算机文本挖掘和途径分析工具进行药物发现,可以促进确定具有局部给药潜力的现有药物,以改善 OM 治疗。